AbbVie Inc.
Pas de trades
Pas de trades
Titres de créance d'entreprises
Vous trouverez ci-dessous la liste des obligations AbbVie Inc., classées par rendement le plus bas. Les investisseurs optent souvent pour les obligations d'une entreprise en raison de leur stabilité accrue en période de volatilité des marchés. Étudiez les prix, les rendements et autres statistiques et trouvez un investissement fiable.
Symbole | YTW % | Prix % | Coupon % | Date d'échéance | Montant en suspens | Valeur nominale | Notation S&P | Notations de Fitch | Émetteur |
|---|---|---|---|---|---|---|---|---|---|
 ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064 | 5,87% | 93,96% | 5,500% | 2064-03-15 | 1,5 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6323042AbbVie Inc. 5.65% 15-MAR-2066 | 5,86% | 96,42% | 5,650% | 2066-03-15 | 500 M USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054 | 5,82% | 94,07% | 5,400% | 2054-03-15 | 3 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048 | 5,80% | 88,43% | 4,875% | 2048-11-14 | 1,75 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049 | 5,80% | 80,04% | 4,250% | 2049-11-21 | 5,75 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6323041AbbVie Inc. 5.55% 15-MAR-2056 | 5,79% | 96,49% | 5,550% | 2056-03-15 | 1,25 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| US287YAW9AbbVie Inc. 4.45% 14-MAY-2046 | 5,79% | 84,31% | 4,450% | 2046-05-14 | 2 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6009613AbbVie Inc. 5.6% 15-MAR-2055 | 5,76% | 97,12% | 5,600% | 2055-03-15 | 750 M USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| 4ABBAbbVie Inc. 4.7% 14-MAY-2045 | 5,75% | 87,97% | 4,700% | 2045-05-14 | 2,7 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044 | 5,69% | 90,53% | 4,850% | 2044-06-15 | 1,01 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044 | 5,67% | 96,09% | 5,350% | 2044-03-15 | 750 M USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| US00287YAM12AbbVie Inc. 4.4% 06-NOV-2042 | 5,66% | 86,67% | 4,400% | 2042-11-06 | 2,6 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042 | 5,64% | 89,28% | 4,625% | 2042-10-01 | 389,22 M USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045 | 5,62% | 88,67% | 4,750% | 2045-03-15 | 827,09 M USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039 | 5,40% | 87,03% | 4,050% | 2039-11-21 | 4 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| US287YAV1AbbVie Inc. 4.3% 14-MAY-2036 | 5,14% | 93,53% | 4,300% | 2036-05-14 | 1 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6323043AbbVie Inc. 4.75% 15-MAR-2036 | 5,14% | 96,95% | 4,750% | 2036-03-15 | 1,5 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| US287YAR0AbbVie Inc. 4.5% 14-MAY-2035 | 5,13% | 95,53% | 4,500% | 2035-05-14 | 2,5 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035 | 5,06% | 96,11% | 4,550% | 2035-03-15 | 1,68 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6009165AbbVie Inc. 5.2% 15-MAR-2035 | 5,05% | 101,01% | 5,200% | 2035-03-15 | 1 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034 | 4,96% | 100,32% | 5,050% | 2034-03-15 | 3 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6322510AbbVie Inc. 4.4% 15-MAR-2033 | 4,88% | 97,14% | 4,400% | 2033-03-15 | 1,25 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6322511AbbVie Inc. 4.125% 15-MAR-2031 | 4,71% | 97,38% | 4,125% | 2031-03-15 | 1,25 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031 | 4,66% | 100,86% | 4,950% | 2031-03-15 | 2 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6009612AbbVie Inc. 4.875% 15-MAR-2030 | 4,62% | 100,73% | 4,875% | 2030-03-15 | 1 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029 | 4,59% | 95,56% | 3,200% | 2029-11-21 | 5,44 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029 | 4,52% | 100,61% | 4,800% | 2029-03-15 | 2,5 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028 | 4,42% | 99,59% | 4,250% | 2028-11-14 | 1,75 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6322513AbbVie Inc. 3.775% 03-MAR-2028 | 4,37% | 98,95% | 3,775% | 2028-03-03 | 1,5 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV6009611AbbVie Inc. 4.65% 15-MAR-2028 | 4,36% | 100,36% | 4,650% | 2028-03-15 | 1,25 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027 | 4,29% | 100,26% | 4,800% | 2027-03-15 | 2,25 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
| ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026 | 4,28% | 99,54% | 2,950% | 2026-11-21 | 3,99 B USD | 1 000,00 USD | A− | — | AbbVie, Inc. |
 XS190919331Allergan Funding SCS 2.625% 15-NOV-2028 | 3,93% | 97,11% | 2,625% | 2028-11-15 | 72,11 M EUR | 1 000,00 EUR | NR | — | Allergan Funding SCS |
| XS162262122Allergan Funding SCS 2.125% 01-JUN-2029 | 3,86% | 95,33% | 2,125% | 2029-06-01 | 36,46 M EUR | 1 000,00 EUR | NR | — | Allergan Funding SCS |
| 4ABGAbbVie Inc. 1.25% 18-NOV-2031 | 3,27% | 90,21% | 1,250% | 2031-11-18 | 650 M EUR | 1 000,00 EUR | A− | — | AbbVie, Inc. |
| XS212591483AbbVie Inc. 2.625% 15-NOV-2028 | 3,25% | 98,60% | 2,625% | 2028-11-15 | 427,79 M EUR | 1 000,00 EUR | A− | — | AbbVie, Inc. |
| XS152090781AbbVie Inc. 2.125% 17-NOV-2028 | 2,99% | 98,05% | 2,125% | 2028-11-17 | 750 M EUR | 1 000,00 EUR | A− | — | AbbVie, Inc. |
| XS212591491AbbVie Inc. 2.125% 01-JUN-2029 | 2,97% | 97,67% | 2,125% | 2029-06-01 | 506,09 M EUR | 1 000,00 EUR | A− | — | AbbVie, Inc. |
| 4ABEAbbVie Inc. 0.75% 18-NOV-2027 | 2,91% | 97,16% | 0,750% | 2027-11-18 | 750 M EUR | 1 000,00 EUR | A− | — | AbbVie, Inc. |
| ABBV6322512AbbVie Inc. FRN 03-MAR-2028 | — | 100,08% | 4,117% | 2028-03-03 | 750 M USD | 1 000,00 USD | A− | — | AbbVie, Inc. |